Solid Biosciences SLDB
Solid Biosciences Inc. · Nasdaq · Biological Products, (No Diagnostic Substances)
$6.48+4.68%close on Oct. 28, 2026 · volume 1.5M · Yahoo Finance
Price, last 47 sessions
Our coverage
Nothing published yet.
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Oct. 19, 2026 | Gabriel Brooks Chief Medical Officer | Sold 10b5-1 plan | 4,374 | $5.62 | $24,582 |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 10 →Other events · Financial statements and exhibits